Rare diseases
Investigational molecules
Locations
Study on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery
FranceStudy of Axi-Cel, Fludarabine Phosphate, and Cyclophosphamide for Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Ineligible for Stem Cell Transplant
FranceStudy of Avapritinib for Children with Solid Tumors Linked to KIT or PDGFRA Signaling
FranceStudy Comparing Selpercatinib, Cabozantinib, and Vandetanib for Patients with Advanced RET-Mutant Medullary Thyroid Cancer
FranceStudy of Retifanlimab, Carboplatin, and Paclitaxel for Patients with Inoperable or Metastatic Anal Canal Squamous Cell Carcinoma Not Treated with Chemotherapy
FranceStudy of TYRA-300 for Patients with Advanced Bladder Cancer and Other Solid Tumors with FGFR3 Gene Changes
FranceStudy of Alectinib and Platinum-Based Chemotherapy for Patients with Resected Stage Ib to IIIa ALK-Positive Non-Small Cell Lung Cancer
FranceStudy on Ibrutinib, CD20 Ab and Venetoclax for Patients with Untreated Mantle Cell Lymphoma
FranceStudy on GR1014 Gel to Prevent Skin Damage from Radiation in Breast Cancer Patients After Lumpectomy
FranceA Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans
FranceStudy of Long-term Safety of Tazemetostat in Patients Who Previously Participated in Tazemetostat Clinical Trials
FranceStudy comparing darolutamide versus hormone therapy (goserelin, leuprorelin, triptorelin, degarelix) in men with untreated hormone-sensitive prostate cancer
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
